PERSPECTIVE THERAPEUTICS, INC. Other Non-Current Assets
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Other Non-Current Assets of $509.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-10
- 2026-06-30: Other Assets, Noncurrent $509.00K.
- 2026-03-31: Other Assets, Noncurrent $490.00K.
- 2025-12-31: Other Assets, Noncurrent $486.00K.
- 2025-09-30: Other Assets, Noncurrent $438.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $509.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $490.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $486.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $438.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $401.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $366.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $405.00K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $694.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $672.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $482.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $487.00K 10-K/A · filed 2025-03-28 | |
| 2023-09-30 | $551.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $573.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $567.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $175.00K 10-K · filed 2024-03-28 | $236.00K 10-KT · filed 2023-05-01 |
| 2022-09-30 | $101.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $107.00K 10-KT · filed 2023-05-01 | |
| 2022-03-31 | $99.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $110.00K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $120.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $130.00K 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $117.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $119.00K 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $128.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $138.00K 10-K · filed 2021-09-27 | |
| 2020-03-31 | $133.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $142.00K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $151.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $162.00K 10-K · filed 2020-09-25 | |
| 2019-03-31 | $160.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $173.00K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $185.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $198.00K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $192.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $204.00K 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $217.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $230.00K 10-K · filed 2018-09-26 | |
| 2017-03-31 | $267.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $278.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $292.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $151.00K 10-K · filed 2017-09-28 | $150.53K 10-K · filed 2016-09-09 |
| 2016-03-31 | $222.53K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $233.01K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $240.40K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $245.03K 10-K · filed 2016-09-09 | |
| 2015-03-31 | $243.17K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $250.90K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $258.64K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $264.08K 10-K · filed 2015-09-14 | |
| 2014-03-31 | $258.62K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $262.70K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $271.39K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $276.51K 10-K · filed 2014-09-29 | |
| 2013-03-31 | $293.58K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $301.07K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $301.44K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $301.69K 10-K · filed 2013-09-30 | |
| 2012-03-31 | $299.66K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $273.25K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $279.47K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $277.18K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |